# EDGAR Filing Document

**Accession Number:** 0001809122
**File Stem:** 0001104659-25-063026
**Filing Date:** 2025-6
**Character Count:** 11165
**Document Hash:** d81dbe572e2d99d14c034d5c64821196
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-063026.hdr.sgml**: 20250626

**ACCESSION NUMBER**: 0001104659-25-063026

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20250626

**FILED AS OF DATE**: 20250626

**DATE AS OF CHANGE**: 20250626

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CureVac N.V.
- **CENTRAL INDEX KEY:** 0001809122
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39446
- **FILM NUMBER:** 251080278

**BUSINESS ADDRESS:**
- **STREET 1:** PAUL-EHRLICH-STRABE 15 TUBINGEN
- **CITY:** BADEN-WURTTEMBERG
- **STATE:** 2M
- **ZIP:** 72076
- **BUSINESS PHONE:** 49 7071 9883 0

**MAIL ADDRESS:**
- **STREET 1:** PAUL-EHRLICH-STRABE 15 TUBINGEN
- **CITY:** BADEN-WURTTEMBERG
- **STATE:** 2M
- **ZIP:** 72076

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CureVac B.V.
- **DATE OF NAME CHANGE:** 20200410

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER<br> PURSUANT TO RULE 13a-16 OR 15d-16<br> UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of June 2025**

**Commission File Number: 001-39446**

**CureVac N.V.**

(*Exact Name of Registrant as Specified in Its Charter*)

**Friedrich-Miescher-Strasse 15, 72076**

**Tübingen, Germany**

**+49 7071 9883 0**

(*Address of principal executive office*)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ⌧ Form 40-F ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes ◻ No ⌧

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes ◻ No ⌧

On June 26, 2025, CureVac N.V. (the "Company") issued a table containing tabulations of the votes cast at the Company's annual general meeting of shareholders.

The information included in this Form 6-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **CureVac N.V.** | **CureVac N.V.** |
|  | (Registrant) | (Registrant) |
| Date: June 26, 2025 | By: | /s/ Alexander Zehnder |
|  |  | *Chief Executive Officer* |

---

EXHIBIT INDEX

---

| | |
|:---|:---|
| EXHIBIT NO. | DESCRIPTION |
| [99.1](tm2519249d1_ex99-1.htm) | [Final Tabulation Table of Votes Cast on the Company's Annual General Meeting of Shareholders.](tm2519249d1_ex99-1.htm) |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| CureVac N.V., Tübingen, Germany<br> Annual General Meeting of Shareholders, June 24, 2025 | ![](tm2519249d1_ex99-1img001.jpg) |

---

**Voting results – Overview**

---

| | | |
|:---|:---|:---|
| Agenda Item 3 | Adoption of the annual accounts over the financial year 2024 - accepted | Adoption of the annual accounts over the financial year 2024 - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 140.132.699 | Yes votes | 99.97 % of the valid votes cast |
| 29.971 | No votes | 0.02 % of the valid votes cast |
| Agenda Item 5 | Release of managing directors from liability for the exercise of their duties during the financial year 2024 - accepted | Release of managing directors from liability for the exercise of their duties during the financial year 2024 - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 140.077.414 | Yes votes | 99.93 % of the valid votes cast |
| 84.986 | No votes | 0.06 % of the valid votes cast |
| Agenda Item 6 | Release of supervisory directors from liability for the exercise of their duties during the financial year 2024 - accepted | Release of supervisory directors from liability for the exercise of their duties during the financial year 2024 - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 139.980.864 | Yes votes | 99.87 % of the valid votes cast |
| 181.750 | No votes | 0.13 % of the valid votes cast |
| Agenda Item 7 | Appointment of Axel Sven Malkomes as member of the Company´s management board - accepted | Appointment of Axel Sven Malkomes as member of the Company´s management board - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 140.139.165 | Yes votes | 99.93 % of the valid votes cast |
| 90.536 | No votes | 0.06 % of the valid votes cast |
| Agenda Item 8 | Reappointment of Jean Stéphenne as member of the Company's supervisory board - accepted | Reappointment of Jean Stéphenne as member of the Company's supervisory board - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 139.838.439 | Yes votes | 99.71 % of the valid votes cast |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;394.767 | No votes | 0.28 % of the valid votes cast |

---

---

| | |
|:---|:---|
| CureVac N.V., Tübingen, Germany<br> General Meeting of Shareholders, June 24, 2025 | ![](tm2519249d1_ex99-1img001.jpg) |

---

---

| | | |
|:---|:---|:---|
| Agenda Item 9 | Appointment of Mehdi Shahidi as member of the Company's supervisory board - accepted | Appointment of Mehdi Shahidi as member of the Company's supervisory board - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28% of the registered share capital) | Number of shares for which valid votes were cast (= 62.28% of the registered share capital) |
| 140.157.629 | Yes votes | 99.94 % of the valid votes cast |
| 71.465 | No votes | 0.05 % of the valid votes cast |
| Agenda Item 10 | Reappointment of Debra Barker as member of the Company's supervisory board - accepted | Reappointment of Debra Barker as member of the Company's supervisory board - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 140.113.153 | Yes votes | 99.91 % of the valid votes cast |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;116.825 | No votes | 0.08 % of the valid votes cast |
| Agenda Item 11 | Reappointment of Craig A. Tooman as member of the Company's supervisory board - accepted | Reappointment of Craig A. Tooman as member of the Company's supervisory board - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 137.277.554 | Yes votes | 97.89 % of the valid votes cast |
| 2.955.849 | No votes | 2.10 % of the valid votes cast |
| Agenda Item 12 | Reappointment of Klaus Schollmeier as member of the Company's supervisory board - accepted | Reappointment of Klaus Schollmeier as member of the Company's supervisory board - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 139.399.557 | Yes votes | 99.40 % of the valid votes cast |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;833.933 | No votes | 0.59 % of the valid votes cast |
| Agenda Item 13 | Reappointment of the external auditor for the financial year 2026 - accepted | Reappointment of the external auditor for the financial year 2026 - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 140.174.534 | Yes votes | 99.96 % of the valid votes cast |
| &nbsp;&nbsp;&nbsp;&nbsp;52.382 | No votes | 0.03 % of the valid votes cast |

---

---

| | |
|:---|:---|
| CureVac N.V., Tübingen, Germany<br> General Meeting of Shareholders, June 24, 2025 | ![](tm2519249d1_ex99-1img001.jpg) |

---

---

| | | |
|:---|:---|:---|
| Agenda Item 14 | Authorisation of the management board to issue shares and to grant rights to subscribe for shares in the Company's capital - accepted | Authorisation of the management board to issue shares and to grant rights to subscribe for shares in the Company's capital - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 135.547.540 | Yes votes | 96.66 % of the valid votes cast |
| &nbsp;&nbsp;&nbsp;&nbsp;4.682.008 | No votes | 3.33 % of the valid votes cast |
| Agenda Item 15 | Authorisation of the management board to limit or exclude pre-emption rights - accepted | Authorisation of the management board to limit or exclude pre-emption rights - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 135.566.093 | Yes votes | 96.67 % of the valid votes cast |
| &nbsp;&nbsp;&nbsp;&nbsp;4.656.298 | No votes | 3.32 % of the valid votes cast |
| Agenda Item 16 | Amendment to the compensation of the members of the Company's supervisory board - accepted | Amendment to the compensation of the members of the Company's supervisory board - accepted |
| 140.238.267 | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) | Number of shares for which valid votes were cast (= 62.28 % of the registered share capital) |
| 136.562.291 | Yes votes | 97.39 % of the valid votes cast |
| &nbsp;&nbsp;&nbsp;&nbsp;3.659.762 | No votes | 2.61 % of the valid votes cast |

---